US-UK pharma deal isn’t enough to get AstraZeneca investing in Britain again
LONDON — AstraZeneca CEO Pascal Soriot says the pharmaceutical giant is still not ready to restart its paused U.K. investments,…
92,830$
0,26%
Echtzeit-Aktienkurs ASTRAZENECA DL-,25 SP.ADR
Bid:
Ask:
Nachrichten zur ASTRAZENECA DL-,25 SP.ADR Aktie
AstraZeneca’s growth engine stays on track despite cost pressures
AstraZeneca PLCs (LSE:AZN, NASDAQ:AZN) full-year results showed the pharmaceutical group navigating a challenging comparison period with a robust...…
FTSE 100 slips as Standard Chartered and BP weigh
The FTSE 100 slipped on Tuesday as investors digested a raft of corporate updates from companies including Barclays, AstraZeneca, and…
KORREKTUR/ROUNDUP: Astrazeneca will 2026 mehr verdienen - Aktie nahe Rekordhoch
(Es wird in der Überschrift und im 1. Absatz klargestellt, dass die Aktie sich ihrem Rekordhoch genähert rpt genähert hat.)…
ROUNDUP: Astrazeneca will auch 2026 mehr verdienen - Aktie auf Rekordhoch
CAMBRIDGE (dpa-AFX) - Der Pharmakonzern Astrazeneca stellt sich nach einem schwungvollen Jahr auf weiteres Wachstum ein und will zugleich…
JEFFERIES stuft ASTRAZENECA auf Buy
NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Astrazeneca nach Zahlen zum vierten Quartal auf "Buy"…
BARCLAYS stuft ASTRAZENECA auf Overweight
LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für Astrazeneca nach Zahlen auf "Overweight" mit einem Kursziel…
AstraZeneca lifts earnings as pipeline delivery and global expansion underpin growth
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) delivered strong full-year results for 2025, driven by solid commercial performance across all major regions and...…
Drugmaker AstraZeneca forecasts sales and profit growth in 2026
AstraZeneca on Tuesday forecast profit and sales growth in 2026, betting on demand for its cancer and cardiovascular treatments while…
AstraZeneca earnings up next after NYSE debut, China expansion By Investing.com
AstraZeneca earnings up next after NYSE debut, China expansion…
Why AstraZeneca is Investing $15bn in Chinese Manufacturing
AstraZeneca will invest US$15bn in China through 2030 to boost R&D, advanced manufacturing and next generation therapies for patients around…
Spotlight On Coca-Cola, Ford, AstraZeneca Earnings
…
FDA Rejects AZNs Saphnelo SubQ Formulation, Priority Tag to Datroway
AstraZeneca wins FDA priority review for Datroway in triple-negative breast cancer, while Saphnelo SC receives a complete response letter.…
Why Astrazeneca (AZN) Dipped More Than Broader Market Today
The latest trading day saw Astrazeneca (AZN) settling at $184.32, representing a -2.17% change from its previous close.…
FDA Rejects Self-Injected Version of AstraZeneca’s Lupus Drug
The US Food and Drug Administration rejected a subcutaneous version of AstraZeneca Plc’s lupus medicine that would make it easier…
Total Voting Rights
2 February 2026Transparency DirectiveVoting rights and capitalThe following notification is made in accordance with the UK Financial Conduct Authoritys Disclosure…
AstraZeneca begins trading directly on the NYSE
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares start trading directly on the New York Stock Exchange today, establishing a harmonised global listing along...…
AstraZeneca begins trading directly on the NYSE
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares start trading directly on the New York Stock Exchange today, establishing a harmonised global listing along...…
AstraZeneca Shares to Start Trading in US After Listing Upgrade
It has said the move will give equal weight to its UK, Swedish and US listings. It reflects the…
AstraZeneca Shares Start Trading in US After Listing Upgrade
Shares of AstraZeneca Plc, the UK’s biggest drugmaker, started trading on the New York Stock Exchange on Monday following a…